Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Lumos Pharma News

    2,82 $ 0,00% +0,00 $
    In : 2,6333 € | 24.04.24 22:00:00 Nasdaq aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A2P12E
    ISIN: US55028X1090
    US-Symbol: LUMO
    Typ: Aktie

    Lumos Pharma News

    08.11.23 - PR Newswire
    Thinking about buying stock in Ventyx Biosciences, Senti Biosciences, PaxMedica, AGNC Investment, or Lumos Pharma?
    Thinking about buying stock in Ventyx Biosciences, Senti Biosciences, PaxMedica, AGNC Investment, or Lumos Pharma? PR Newswire
    18.09.19 - PR Newswire
    Thinking about buying stock in Aurora Cannabis, DavidsTea, NewLink Genetics, SINTX Technologies, or Spi Energy?
    Thinking about buying stock in Aurora Cannabis, DavidsTea, NewLink Genetics, SINTX Technologies, or Spi Energy? PR Newswire
    18.01.17 - PR Newswire
    Lifshitz & Miller Law Firm Announces Investigation of DaVita Inc., First NBC Bank Holdings Company, Fresenius Medical Care AG & Co. KGAA, Inotek Pharmaceuticals Corporation, Natural Health Tre
    Lifshitz & Miller Law Firm Announces Investigation of DaVita Inc., First NBC Bank Holdings Company, Fresenius Medical Care AG & Co. KGAA, Inotek Pharmaceuticals Corporation, ...
    24.06.16 - PR Newswire
    SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving NewLink Genetics Corporation and a Lead Plaintiff Deadline of July 11, 2016
    SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving NewLink Genetics Corporation and a Lead Plaintiff ...
    10.06.16 - PR Newswire
    NEWLINK SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Agains
    NEWLINK SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff ...
    06.06.16 - PR Newswire
    Law Offices of Marc S. Henzel Announces Investigation of Companies for Violations of the Federal Securities Laws
    Law Offices of Marc S. Henzel Announces Investigation of Companies for Violations of the Federal Securities Laws PR Newswire
    24.05.16 - PR Newswire
    Lifshitz & Miller Law Firm Announces Investigation of Code Rebel Corporation, Domino's Pizza, Inc., Energy Recovery, Inc., Intercloud Systems, Inc., Inventure Foods, Inc., Liquidity Services, Inc.
    Lifshitz & Miller Law Firm Announces Investigation of Code Rebel Corporation, Domino's Pizza, Inc., Energy Recovery, Inc., Intercloud Systems, Inc., Inventure Foods, Inc., Liquidity ...
    20.05.16 - PR Newswire
    SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in NewLink Genetics Corporation of Class Action Lawsuit and Upcoming Deadline - NLNK
    SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in NewLink Genetics Corporation of Class Action Lawsuit and Upcoming ...
    20.05.16 - PR Newswire
    Shareholder Rights Law Firm Johnson & Weaver, LLP Initiates Investigations of; NewLink Genetics Corporation, DeVry Education Group, Inc., Target Corporation, La Quinta Holdings Inc and Carbylan Th
    Shareholder Rights Law Firm Johnson & Weaver, LLP Initiates Investigations of; NewLink Genetics Corporation, DeVry Education Group, Inc., Target Corporation, La Quinta ...
    17.05.16 - PR Newswire
    SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against NewLink Genetics Corporation (NLNK) and Lead Plaintiff Deadline: July 11, 2016
    SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against NewLink Genetics Corporation (NLNK) and Lead Plaintiff Deadline: July 11, ...
    10.05.16 - PR Newswire
    SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of NewLink Genetics Corporation (NLNK)
    SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of NewLink Genetics Corporation (NLNK) PR Newswire
    11.04.16 - The Motley Fool
    Ebola kann uns Investoren eine wichtige Lektion über die Wirtschaftlichkeit lehren
    Etwas mehr als zwei Jahre sind vergangen, seit die Angst vor der Ebola-​Pandämie die Welt erschütterte. Aber laut der Weltgesundheitsorganisation wird der Ebola-​Virus nicht mehr ...
    03.02.16 - PR Newswire
    Covered Call Alerts For Kinder Morgan, Dow Chemical, NewLink Genetics, Du Pont and Kohls Released By InvestorsObserver
    Covered Call Alerts For Kinder Morgan, Dow Chemical, NewLink Genetics, Du Pont and Kohls Released By InvestorsObserver PR Newswire
    18.08.15 - PR Newswire
    Critical Alerts For Exelixis, Opko Health, Chipotle Mexican Grill, NewLink Genetics and Cliffs Natural Resources Released By InvestorsObserver
    Critical Alerts For Exelixis, Opko Health, Chipotle Mexican Grill, NewLink Genetics and Cliffs Natural Resources Released By InvestorsObserver PR Newswire
    02.11.14 - Börse Online
    NewLink Genetics-Aktie: Ebola-Killer dringend gesucht
    Die NewLink Genetics zählt zu den Pharmafirmen, die sich Hoffnung auf einen Erfolg bei der Entwicklung eines Impfstoffs gegen das tödliche Virus machen. Von Stephan Bauer ...
    30.10.14 - Euro am Sonntag
    NewLink Genetics: Ebola-Killer dringend gesucht
    03.06.13 - PR Newswire
    NewLink Genetics' Algenpantucel-L Shows Encouraging Disease-Free and Overall Survival in Phase 2 Study in Resected Pancreatic Cancer
    NewLink Genetics' Algenpantucel-​L Shows Encouraging Disease-​Free and Overall Survival in Phase 2 Study in Resected Pancreatic Cancer Median Overall Survival was More than ...
    03.06.13 - PR Newswire
    NewLink Genetics Presents Results from Two Phase 1 Studies with Immunotherapy Agent, Indoximod, at the ASCO 2013 Annual Meeting
    NewLink Genetics Presents Results from Two Phase 1 Studies with Immunotherapy Agent, Indoximod, at the ASCO 2013 Annual Meeting Data Demonstrate Evidence of ...
    01.06.13 - PR Newswire
    NewLink Genetics Presents Positive Phase 2 Data on Novel Immunotherapy, Tergenpumatucel-L, in Non-Small Cell Lung Cancer at the ASCO 2013 Annual Meeting
    NewLink Genetics Presents Positive Phase 2 Data on Novel Immunotherapy, Tergenpumatucel-​L, in Non-Small Cell Lung Cancer at the ASCO 2013 Annual Meeting Data ...
    29.05.13 - PR Newswire
    NewLink Genetics to Present at the Jefferies 2013 Healthcare Conference
    NewLink Genetics to Present at the Jefferies 2013 Healthcare Conference PR Newswire

    Newssuche

    Videos

    newspaper
    24.04.24
    Technical Trading: AUD/USD mit Mega Chance
    AUD/USD Long Typ: Turbo Open End WKN: UM0EHU Hebel: 6,42 Laufzeit: OpenEnd Einstieg: Market ... Mehr »